Four new curcuminoid pyrazoles (1-4) were synthesized by one-pot combinatorial modification of the total curcuminoid extract, through chemical transformation of β-diketone functionalities by p-chlorophenylhydrazine. All four curcuminoid pyrazoles were identified by spectroscopic methods, and the structure of compound 4 was further confirmed by single-crystal X-ray analysis. Compounds 1 and 2, with a long conjugated system and at least one methoxy substitution, showed a more potent antiviral effect than did the corresponding natural product, curcumin. The rapid synthesis of curcuminoid pyrazoles with improved antiviral activity highlights the great potential of one-pot combinatorial modification for the diversification of natural products with improved bioactivities.
Introduction
Curcuminoids are diarylheptanoids, mainly existing in the families Zingiberaceae and Betulaceae, etc. The skeletons are constructed by a heptane core with aryl groups substituted at the 1-and 7-positions. The most common representative compounds are curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcuminoids have been shown to exhibit antioxidant, 1 anti-inflammatory, 2 anticancer, 3 hypoglycemic, 4 and anti-HIV 5 bioactivities. In recent years, curcuminoid compounds have been used for the treatment of cardiovascular [6] [7] [8] and Alzheimer's diseases, 9 and clinical trials of curcumin as a therapeutic drug for advanced pancreatic cancer have been carried out in Phase II. 10 Recently, curcumin was found to prevent the replication of respiratory syncytial virus (RSV). 11 In addition, because of the color stability and very low toxicity, curcuminoids are widely used as food additives and coloring agents. Curcumin is safe even at a high dose of 8.0 g/day, 12 and oral consumption of curcumin up to 12 g/day is tolerable. 13 However, the bioavailability of curcumin is poor, which limits its clinical application. 14 Structural modification of curcumin has received attention worldwide and led to a number of bioactive curcumin derivatives. [15] [16] [17] [18] [19] Among these derivatives, curcumin pyrazoles were found to show antimicrobial 20 and antitumor activities. 21, 22 CNB-001, a pyrazole derivative of curcumin, was reported to exhibit neurotrophic activity, which can be used for the treatment of Parkinson's Disease and ischemic stroke. 
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In recent years, increasing efforts have been invested in the application of one-pot combinatorial modification to create structural diversity, in which multiple starting materials and reactants are put in a single container to undergo chemical reactions. [26] [27] [28] [29] This approach can be regarded as "green" technology because it improves the efficiency of the chemical reaction and minimizes waste by abolishing complicated separation and purification of intermediates.
In this paper, the one-pot combinatorial modification strategy was used to diversify both the major and minor curcumin analogs, which resulted in four new curcuminoid pyrazoles (Figure1). These new derivatives showed more potent antiviral effects against RSV than did the natural product curcumin. We reported herein the modification strategy, structures of the curcuminoid pyrazoles, and the antiviral properties.
Materials and methods
Unless otherwise noted, reagents were purchased from commercial suppliers and used without further purification. Column chromatographies were performed on silica gel (200-400 mesh) (Qingdao Marine Chemical Plant, Qingdao, People's Republic of China), reverse-phase C18 silica gel (Merck KGaA, Darmstadt, Germany), and Sephadex ® LH-20 (Pharmacia Biotec AB, Uppsala, Sweden). High-performance liquid chromatography (HPLC) analysis was carried out using an Agilent 1100 HPLC instrument, coupled to an Agilent 1100 diode array detector (DAD) (Agilent Technologies, Santa Clara, CA, USA); data were analyzed by using the Agilent ChemStation. Solvents used for column chromatography were of analytical grade (Shanghai Chemical Plant, Shanghai, People's Republic of China), and solvents used for HPLC were of chromatographic grade (Thermo Fisher Scientific Inc., Waltham, MA, USA). Ultraviolet (UV)-visible (UV-Vis) absorption was recorded in MeOH on a JASCO V-550 UV/Vis spectrophotometer (JASCO Corp, Tokyo, Japan). Infrared (IR) absorption was recorded on a JASCO FT/IR-480 Plus Fourier transform infrared spectrometer using KBr pellet. Nuclear magnetic resonance (NMR) spectra, including 1 H-NMR, 13 C-NMR, distortionless enhancement by polarization transfer (DEPT)-135 NMR, and two-dimensional (2D)-NMR spectra, were recorded on a Bruker AV-300 or AV-400 (Bruker Corporation, Billerica, MA, USA) spectrometer in dimethyl sulfoxide (DMSO), with tetramethylsilane as the internal reference, and the δ values, in ppm, were referenced to either the residual CH 3 
Plant material
The rhizomes of C. longa purchased in a Chinese medicinal herbs shop in Guangdong Province, People's Republic of China, in July 2010. The herbal material was identified at the Institute of Traditional Chinese Medicine and Nature Products, Jinan University, and a herbal specimen (number JH2010-1) was deposited.
enriching the total curcuminoids
The dried rhizomes (5 kg) were extracted with 95% ethanol (10 L ×3), and the solvent was evaporated in vacuo to give crude extract (650 g). The crude extract was suspended in distilled water and extracted with ethyl acetate to afford the 
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Curcuminoid pyrazoles with antiviral effects ethyl acetate fraction (474 g). Then the ethyl acetate fraction (100 g) was subjected to macroporous resin chromatography eluted with ethanol-H 2 O (30%, 70%, and 95%). The 70% ethanol eluted fraction was condensed under vacuum to afford the total curcuminoids (54 g).
Reaction of the total curcuminoids with p-chlorophenylhydrazine hydrochloride
The total curcuminoids (20 g) was dissolved in glacial acetic acid (200 mL), and p-chlorophenylhydrazine hydrochloride (20 g ) was added to the solution. The reaction mixture was stirred and refluxed for 12 hours. The resulting mixture was cooled to room temperature, and the solvent was evaporated in vacuo. The residue was dissolved in ethyl acetate and washed with distilled water to remove acetic acid, and the ethyl acetate layer was evaporated in vacuo to afford the semisynthetic mixture (30.4 g).
isolation of reaction products
The semisynthetic mixture was subjected to silica gel (200-300 mesh) and eluted with cyclohexane-ethyl acetate 
1-(4-
Chlorophenyl)-3-[2-(4- hydroxyphenylethenyl)]-5-[2-(4-hydroxy- 3-methoxyphenylethenyl)]pyrazole (compound 1)
X-ray crystallographic analysis of compound 4
Data were collected using an Agilent Sapphire CCD with a CuKα radiation, λ=1.54184 Å at 173.00(2) K. Crystal data: C 25 H 23 ClO 2 N 2 , monoclinic, space group P2 1 /n; unit cell dimensions were determined to be a=13.2127 (2) 
antiviral assay
The cytopathic effects (CPE) reduction method was used. 30 Briefly, HEp-2 cells (American Type Culture Collection, Manassas, VA, USA) were cultured in 96-well plates and incubated at 37°C in a humidified atmosphere supplied with 5% CO 2 . To the confluent cell monolayers in 96-well plates, a fixed quantity of RSV virus (American Type Culture Collection) (50% tissue culture infective dose [TCID50] =100) in suspension was added to the monolayers of HEp-2 cells. The samples were dissolved in DMSO and were serially twofold diluted with the assay buffer (final DMSO concentration was less than 0.1%). After the samples were added, the plates were incubated at 37°C in a humidified CO 2 atmosphere for 4-6 days. The virus-induced CPE were scored under light microscopy in comparison with the virus control. The maximal concentration without cytotoxic effect was defined as the maximal noncytotoxic concentration (MNCC). The concentration that showed 50% cytotoxic effect was defined as CC 50 . The concentration of the sample that reduced 50% of CPE with respect to the virus control was estimated from the plots of the data and was defined as the 50% inhibitory concentration (IC 50 ). The selectivity against RSV virus was characterized by the therapeutic index (TI) TI = CC 50 /IC 50 .
(1)
Results and discussion
The D101 macroporous resin was used to enrich the total curcuminoids from the ethyl acetate extract of C. longa. Then the total curcuminoids was reacted with p-chlorophenylhydrazine to afford a semisynthetic mixtures, which showed antiviral effect against RSV, with an IC 50 value of 25 µg/mL. The subsequent isolation resulted in four new curcuminoid pyrazoles (1−4). 13 C-NMR spectra of 3 were similar to those of 1 except that no methoxy signal was observed, which was consistent with the ESI-MS data. The AA′BB′ coupling patterns also confirmed that the benzene rings were all monosubstituted. Accordingly, compound 3 was identified as 1-(4-chlorophenyl)-3,5-bis[2-(4-hydroxyphenylethenyl)]pyrazole, which was the reaction product of bisdemethoxycurcumin.
The molecular formula of 4 was established as C 25 Similar to 3, no methoxy signal was observed in the NMR spectra of 4. Accordingly, compound 4 was identified as 1-(4-chlorophenyl)-3,5-bis [2-(4-hydroxyphenylethyl)]pyrazole, which was the reaction product of tetrahydrobisdemethoxycurcurcumin. Furthermore, the molecular structure of 4 was confirmed by X-ray crystallographic analysis (Figure 2 ).
In solid state, the benzene rings A and B had dihedral angles of 55.8° and 100.3° with the p-chlorophenyl moiety (ring C), respectively.
The curcuminoid pyrazoles 1−4 were tested for the antiviral effects against RSV (Table 1) . Both compounds 1 and 2, with a long conjugated system and at least one methoxy substitution, showed similar antiviral effects, with an IC 50 value of 12.5 µM, which is much more potent than the natural product, curcumin (IC 50 .50 µM). Though 1 and 2 showed similar potency, the MNCC of 2 was twofold higher than that of 1, indicating a much higher safety of 2. Compounds 3 and 4 were inactive at 50 µM, indicating that the conjugated system, methoxy substitution, and chlorophenyl substituted pyrazole ring might be beneficial to the antiviral property. It is noteworthy that the cytotoxic effects of 1−4 were tested against prostate cancer cells (PC3 and LNCaP); however all these derivatives demonstrated decreased activities as compared with those of curcumin. In summary, four new curcuminoid pyrazoles (1-4) were rapidly synthesized by combinatorial modification of the total curcuminoid extract of C. longa. Among these curcuminoid pyrazoles, compound 2 was the only one derived from the major component curcumin; while compounds 1, 3, and 4 were derived from the minor components demethoxycurcumin bisdemethoxycurcumin and tetrahydrobisdemethoxycurcurcumin, respectively. If the conventional structural modification strategy -starting first with extraction and purification of these minor components, followed by chemical modification -is employed, it will be time-consuming and cost ineffective. Furthermore, compounds 1 and 2, with a long conjugated system and at least one methoxy substitution, showed more potent antiviral effect than did the corresponding natural product, curcumin. The rapid synthesis of curcuminoid pyrazoles with improved antiviral activity highlights the great potential of one-pot combinatorial modification for the diversification of natural products with improved bioactivities.
